Copia Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.4K Sell
33
-1
-3% -$1.01K 0.02% 240
2025
Q4
$36.5K Hold
34
0.03% 225
2025
Q3
$25.9K Hold
34
0.02% 247
2025
Q2
$26.5K Buy
34
+3
+10% +$2.33K 0.02% 215
2025
Q1
$25.6K Buy
31
+6
+24% +$4.99K 0.02% 205
2024
Q4
$19.3K Buy
+25
New +$20.7K 0.02% 215

Other funds holding LLY

Copia Wealth Management's LLY Position: Q1 2026 in Review

Copia Wealth Management reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $1.01K and leaving 33 shares worth $30.4K. The position accounts for 0.02% of the portfolio, ranked #240.

Copia Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $36.5K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Copia Wealth Management held 33 shares of Eli Lilly worth $30.4K as of Q1 2026.
  • Copia Wealth Management sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.02% of Copia Wealth Management's portfolio in Q1 2026, its #240 holding.
  • Copia Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Copia Wealth Management's Eli Lilly position peaked at $36.5K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Copia Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.